The FDA has approved Rezdiffra, the first medication for severe non-alcoholic fatty liver disease, showing improvement in liver scarring in NASH patients. NASH affects millions, linked to health issues like high blood pressure and diabetes. Rezdiffra targets root causes of NASH, with common side effects of diarrhoea and nausea.
US approves first medication for severe non-alcoholic fatty liver disease
![US approves first medication for severe non-alcoholic fatty liver disease]()
Reviewed by karthi
on
March 14, 2024
Rating:
No comments: